Didier Desmaele
10Patents
1h-index
34Co-inventors
50Inventor score
Filing activity: Jan 16, 2001 → Sep 24, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6670377B1 | Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof | Chemistry; Metallurgy | 14 | Expired |
| US7064133B2 | Quinoline derivatives process of synthesis and medicaments containing these derivatives | Human Necessities | 1 | Expired |
| US7479497B2 | Use of quinoline derivatives with anti-integrase effect and applications thereof | Human Necessities | 1 | Expired |
| US10125157B2 | Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation | Chemistry; Metallurgy | 0 | Active |
| US10213413B2 | Antiviral agents directed against respiratory syncytial virus | Chemistry; Metallurgy | 0 | Active |
| US10098901B2 | Derivatives of oxazaphosphorines and therapeutic uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8748414B2 | Statin nanoparticles | Chemistry; Metallurgy | 0 | Active |
| US11939577B2 | Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease | Chemistry; Metallurgy | 0 | Active |
| US9295630B2 | Vitamin C complexes | Emerging Cross-Sectional Technologies | 0 | Active |
| US9428530B2 | Derivatives of oxazaphosphorines that are pre-activated, use and method of preparation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.